MedRx Statistics

Total Valuation

MedRx has a market cap or net worth of JPY 3.88 billion. The enterprise value is 1.55 billion.

Market Cap	3.88B
Enterprise Value	1.55B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

MedRx has 47.35 million shares outstanding. The number of shares has increased by 28.43% in one year.

Current Share Class	n/a
Shares Outstanding	47.35M
Shares Change (YoY)	+28.43%
Shares Change (QoQ)	+9.14%
Owned by Insiders (%)	4.66%
Owned by Institutions (%)	2.19%
Float	44.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.25
PB Ratio	1.44
P/TBV Ratio	1.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.67
EV / Sales	6.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.12

Current Ratio	28.12
Quick Ratio	27.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -24.19% and return on invested capital (ROIC) is -16.73%.

Return on Equity (ROE)	-24.19%
Return on Assets (ROA)	-16.14%
Return on Capital (ROIC)	-16.73%
Revenue Per Employee	11.59M
Profits Per Employee	-26.41M
Employee Count	22
Asset Turnover	0.10
Inventory Turnover	0.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-45.70%
50-Day Moving Average	87.96
200-Day Moving Average	115.49
Relative Strength Index (RSI)	44.12
Average Volume (20 Days)	540,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedRx had revenue of JPY 255.00 million and -581.00 million in losses. Loss per share was -14.10.

Revenue	255.00M
Gross Profit	254.00M
Operating Income	-643.00M
Pretax Income	-583.00M
Net Income	-581.00M
EBITDA	-598.75M
EBIT	-643.00M
Loss Per Share	-14.10

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	2.33B
Total Debt	n/a
Net Cash	2.33B
Net Cash Per Share	49.26
Equity (Book Value)	2.62B
Book Value Per Share	57.11
Working Capital	2.33B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 99.61%, with operating and profit margins of -252.16% and -227.84%.

Gross Margin	99.61%
Operating Margin	-252.16%
Pretax Margin	-228.63%
Profit Margin	-227.84%
EBITDA Margin	-234.80%
EBIT Margin	-252.16%
FCF Margin	n/a

Dividends & Yields

MedRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.43%
Shareholder Yield	-28.43%
Earnings Yield	-17.19%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedRx has an Altman Z-Score of 37.32.

Altman Z-Score	37.32
Piotroski F-Score	n/a